BACKGROUND: Proliferation and tumor differentiation captured by the genomic grade index (GGI) are important prognostic indicators in breast cancer (BC) especially for the estrogen receptor positive (ER+) disease. The aims of this study were to convert this microarray index to a qRT-PCR assay (PCR-GGI), which could be realized on formalin fixed paraffin embedded samples (FFPE), and to assess its prognostic performance and predictive value of clinical benefit in early and advanced ER+ BC patients treated with tamoxifen. METHODS: The accuracy and concordance of the PCR-GGI with the GGI was assessed using BC patients for which frozen and FFPE tissues as well as microarray data were available (n = 19). The evaluation of the prognostic value of t...
Background: We critically evaluated the available evidence on genomic tests in breast cancer to defi...
Objectives - Reliable assessment of estrogen, progesterone (ER and PR), and HER2 receptor status are...
The molecular profiling of breast tumors using the powerful microarray technology has uncovered the ...
BACKGROUND: Proliferation and tumor differentiation captured by the genomic grade index (GGI) are im...
Background: Proliferation and tumor differentiation captured by the genomic grade index (GGI) are im...
The Genomic Grade Index (GGI) was previously developed, evaluated on frozen tissue, and shown to be ...
Background: Molecular characterization of tumour tissue in limited archived formalin fixed, paraffin...
Background: we have previously shown that the Gene expression Grade Index (GGI) was able to identify...
BACKGROUND: We have previously shown that the Gene expression Grade Index (GGI) was able to identify...
Gene profiling may improve prognostic accuracy in patients with early breast cancer, but this techno...
Purpose: Genomic Grade Index (GGI) is a 97-gene signature that improves histologic grade (HG) classi...
Introduction: Breast cancer is the most common malignancy in women worldwide. It is a significant ca...
Purpose: To compare clinical, immunohistochemical (IHC), and gene expression models of prognosis app...
INTRODUCTION: Predicting the clinical course of breast cancer is often difficult because it is a div...
PURPOSE: Histologic tumor grade is a well-established prognostic factor for breast cancer, and tumor...
Background: We critically evaluated the available evidence on genomic tests in breast cancer to defi...
Objectives - Reliable assessment of estrogen, progesterone (ER and PR), and HER2 receptor status are...
The molecular profiling of breast tumors using the powerful microarray technology has uncovered the ...
BACKGROUND: Proliferation and tumor differentiation captured by the genomic grade index (GGI) are im...
Background: Proliferation and tumor differentiation captured by the genomic grade index (GGI) are im...
The Genomic Grade Index (GGI) was previously developed, evaluated on frozen tissue, and shown to be ...
Background: Molecular characterization of tumour tissue in limited archived formalin fixed, paraffin...
Background: we have previously shown that the Gene expression Grade Index (GGI) was able to identify...
BACKGROUND: We have previously shown that the Gene expression Grade Index (GGI) was able to identify...
Gene profiling may improve prognostic accuracy in patients with early breast cancer, but this techno...
Purpose: Genomic Grade Index (GGI) is a 97-gene signature that improves histologic grade (HG) classi...
Introduction: Breast cancer is the most common malignancy in women worldwide. It is a significant ca...
Purpose: To compare clinical, immunohistochemical (IHC), and gene expression models of prognosis app...
INTRODUCTION: Predicting the clinical course of breast cancer is often difficult because it is a div...
PURPOSE: Histologic tumor grade is a well-established prognostic factor for breast cancer, and tumor...
Background: We critically evaluated the available evidence on genomic tests in breast cancer to defi...
Objectives - Reliable assessment of estrogen, progesterone (ER and PR), and HER2 receptor status are...
The molecular profiling of breast tumors using the powerful microarray technology has uncovered the ...